What does CUSIP 405024100 represent in this 13F holders report?

CUSIP 405024100 is the security identifier for HAE - HAEMONETICS CORP - Common Stock used to aggregate holder disclosures.

How many institutions held HAE - HAEMONETICS CORP - Common Stock in Q2 2014?

172 institutional investors reported HAE - HAEMONETICS CORP - Common Stock for Q2 2014. Use the holders table for investor-level position and value details.

HAEMONETICS CORP - Common Stock (HAE)

CUSIP: 405024100

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / Common Stock
Shares outstanding: 46,480,294
Total 13F shares: 54,462,831
Share change: +221,410
Total reported value: $1,921,442,064
Price per share: $35.28
Number of holders: 172
Value change: +$18,983,073
Number of buys: 82
Number of sells: 101

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 405024100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HAE - HAEMONETICS CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Neuberger Berman Group LLC	13F	Company	12%	5,676,833	$185,008,000	—	31 Mar 2014	13F
VANGUARD GROUP INC	13F	Company	7.6%	3,538,417	$115,317,000	—	31 Mar 2014	13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC	13F	Company	6.5%	3,042,669	$99,161,000	—	31 Mar 2014	13F
BlackRock Fund Advisors	13F	Company	6.2%	2,892,523	$94,267,000	—	31 Mar 2014	13F
FMR LLC	13F	Company	4.8%	2,232,800	$72,767,000	—	31 Mar 2014	13F
PRUDENTIAL PLC	13F	Company	3.7%	1,718,538	$56,007,000	—	31 Mar 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	3%	1,414,040	$46,084,000	—	31 Mar 2014	13F
Van Berkom & Associates Inc.	13F	Company	2.7%	1,258,322	$41,009,000	—	31 Mar 2014	13F
SNYDER CAPITAL MANAGEMENT L P	13F	Company	2.6%	1,222,547	$39,843,000	—	31 Mar 2014	13F
Camber Capital Management LP	13F	Company	2.6%	1,202,000	$39,173,000	—	31 Mar 2014	13F
STATE STREET CORP	13F	Company	2.5%	1,179,082	$38,428,000	—	31 Mar 2014	13F
Champlain Investment Partners, LLC	13F	Company	2.4%	1,137,670	$37,077,000	—	31 Mar 2014	13F
ANCHOR CAPITAL ADVISORS LLC	13F	Company	2.4%	1,119,060	$36,470,000	—	31 Mar 2014	13F
CAMBIAR INVESTORS LLC	13F	Company	2.4%	1,113,673	$36,295,000	—	31 Mar 2014	13F
Black Creek Investment Management Inc.	13F	Company	2.2%	1,014,941	$33,077,000	—	31 Mar 2014	13F
FRANKLIN RESOURCES INC	13F	Company	2.2%	1,000,000	$32,590,000	—	31 Mar 2014	13F
AMERIPRISE FINANCIAL INC	13F	Company	2%	943,589	$30,753,000	—	31 Mar 2014	13F
CI INVESTMENTS INC.	13F	Company	2%	914,801	$29,813,000	—	31 Mar 2014	13F
Boston Trust Walden Corp	13F	Company	1.9%	879,696	$28,669,000	—	31 Mar 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.8%	851,391	$27,746,000	—	31 Mar 2014	13F
NORTHERN TRUST CORP	13F	Company	1.7%	787,365	$25,660,000	—	31 Mar 2014	13F
Invesco Ltd.	13F	Company	1.6%	762,976	$24,866,000	—	31 Mar 2014	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.6%	760,777	$24,793,000	—	31 Mar 2014	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	1.6%	736,378	$23,998,000	—	31 Mar 2014	13F
HERMES INVESTMENT MANAGEMENT LTD	13F	Company	1.6%	728,123	$23,730,000	—	31 Mar 2014	13F
AMERICAN CAPITAL MANAGEMENT INC	13F	Company	1.5%	718,380	$23,412,000	—	31 Mar 2014	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	1.5%	708,000	$23,074,000	—	31 Mar 2014	13F
ROYAL BANK OF CANADA	13F	Company	1.5%	697,785	$22,740,000	—	31 Mar 2014	13F
MACQUARIE GROUP LTD	13F	Company	1.5%	681,334	$22,205,000	—	31 Mar 2014	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.4%	635,330	$20,705,000	—	31 Mar 2014	13F
Epoch Investment Partners, Inc.	13F	Company	1.2%	547,860	$17,855,000	—	31 Mar 2014	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	1.2%	538,000	$17,533,000	—	31 Mar 2014	13F
Bank of New York Mellon Corp	13F	Company	1.1%	529,842	$17,268,000	—	31 Mar 2014	13F
Perkins Investment Management, LLC	13F	Company	0.99%	460,389	$15,004,000	—	31 Mar 2014	13F
KESTREL INVESTMENT MANAGEMENT CORP	13F	Company	0.95%	441,250	$14,380,000	—	31 Mar 2014	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.92%	427,946	$13,947,000	—	31 Mar 2014	13F
CHARTWELL INVESTMENT PARTNERS/PA	13F	Company	0.84%	390,544	$12,728,000	—	31 Mar 2014	13F
NORGES BANK	13F	Company	0.8%	371,584	$12,110,000	—	31 Mar 2014	13F
SENTINEL ASSET MANAGEMENT, INC.	13F	Company	0.79%	365,940	$11,926,000	—	31 Mar 2014	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.71%	330,479	$10,771,000	—	31 Mar 2014	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.64%	296,424	$9,660,000	—	31 Mar 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.6%	276,945	$9,025,000	—	31 Mar 2014	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.59%	271,919	$8,862,000	—	31 Mar 2014	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.55%	257,300	$8,385,407	—	31 Mar 2014	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.55%	254,226	$8,285,000	—	31 Mar 2014	13F
MANAGED ACCOUNT ADVISORS LLC	13F	Company	0.52%	242,020	$7,888,000	—	31 Mar 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.5%	234,262	$7,634,000	—	31 Mar 2014	13F
RUSSELL FRANK CO/	13F	Company	0.5%	230,581	$7,514,000	—	31 Mar 2014	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.47%	219,188	$7,143,000	—	31 Mar 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.46%	212,157	$6,914,000	—	31 Mar 2014	13F

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2014

As of 30 Jun 2014, HAEMONETICS CORP - Common Stock (HAE) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,462,831 shares. The largest 10 holders included Neuberger Berman Group LLC, VANGUARD GROUP INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Fund Advisors, FMR LLC, WELLINGTON MANAGEMENT CO LLP, BlackRock Institutional Trust Company, N.A., WESTWOOD HOLDINGS GROUP INC, Van Berkom & Associates Inc., and PRUDENTIAL PLC. This page lists 172 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders

187

Q2 2014 holders

172

Holder diff

-15

Investor	Q1 2014 Shares	Q2 2014 Shares	Share Diff	Share Chg %	Q1 2014 Value $	Q2 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.